Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Novartis
Medtronic
Fish and Richardson
Moodys
UBS
AstraZeneca
McKinsey
QuintilesIMS
Boehringer Ingelheim

Generated: October 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203469

« Back to Dashboard
NDA 203469 describes ICLUSIG, which is a drug marketed by Ariad and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the ICLUSIG profile page.

The generic ingredient in ICLUSIG is ponatinib hydrochloride. One supplier is listed for this compound. Additional details are available on the ponatinib hydrochloride profile page.

Summary for NDA: 203469

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:3
Formulation / Manufacturing:see details

Pharmacology for NDA: 203469

Mechanism of ActionProtein Kinase Inhibitors

Suppliers and Packaging for NDA: 203469

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ICLUSIG
ponatinib hydrochloride
TABLET;ORAL 203469 NDA ARIAD Pharmaceuticals, Inc. 76189-533 76189-533-30 30 TABLET, FILM COATED in 1 BOTTLE (76189-533-30)
ICLUSIG
ponatinib hydrochloride
TABLET;ORAL 203469 NDA ARIAD Pharmaceuticals, Inc. 76189-534 76189-534-30 30 TABLET, FILM COATED in 1 BOTTLE (76189-534-30)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrengthEQ 15MG BASE
Approval Date:Dec 14, 2012TE:RLD:Yes
Regulatory Exclusivity Expiration:Dec 14, 2017
Regulatory Exclusivity Use:NEW CHEMICAL ENTITY
Regulatory Exclusivity Expiration:Dec 14, 2019
Regulatory Exclusivity Use:ORPHAN DRUG EXCLUSIVITY
Patent:► SubscribePatent Expiration:Dec 22, 2026Product Flag?YSubstance Flag?YDelist Request?


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Covington
Cerilliant
Baxter
McKesson
Mallinckrodt
Johnson and Johnson
Chinese Patent Office
Harvard Business School
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot